Paper7654479
Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole.
van der Ven AJ and 4 others. Br J Clin Pharmacol, 1995. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Papers, record 7654479. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7654479
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Seropositivity | Major topic |
| Sulfamethoxazole | Major topic |
| Adult | |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3521428 | Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. | Ann Intern Med | 1986 | https://conductscience.org/library/papers/3521428 | PubMed |
| 2 | 7820261 | Isolation, identification and determination of sulfamethoxazole and its known metabolites in human plasma and urine by high-performance liquid chromatography. | J Chromatogr B Biomed Appl | 1994 | https://conductscience.org/library/papers/7820261 | PubMed |
| 3 | 6138645 | Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. | Lancet | 1983 | https://conductscience.org/library/papers/6138645 | PubMed |
| 4 | 6230976 | Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. | Ann Intern Med | 1984 | https://conductscience.org/library/papers/6230976 | PubMed |
| 5 | 6231873 | Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. | Ann Intern Med | 1984 | https://conductscience.org/library/papers/6231873 | PubMed |
| 6 | 3873229 | The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. | Arch Intern Med | 1985 | https://conductscience.org/library/papers/3873229 | PubMed |
| 7 | 4075255 | In vitro evaluation of a toxic metabolite of sulfadiazine. | Can J Physiol Pharmacol | 1985 | https://conductscience.org/library/papers/4075255 | PubMed |
| 8 | 2870332 | Serum trimethoprim and sulphamethoxazole levels in AIDS. | Lancet | 1986 | https://conductscience.org/library/papers/2870332 | PubMed |
| 9 | 3346843 | Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. | J Pharmacol Exp Ther | 1988 | https://conductscience.org/library/papers/3346843 | PubMed |
| 10 | 3260759 | Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. | Ann Intern Med | 1988 | https://conductscience.org/library/papers/3260759 | PubMed |
| 11 | 2913915 | Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites. | Ann Intern Med | 1989 | https://conductscience.org/library/papers/2913915 | PubMed |
| 12 | 2784648 | Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. | Ann Intern Med | 1989 | https://conductscience.org/library/papers/2784648 | PubMed |
| 13 | 2784973 | Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. | Biol Chem Hoppe Seyler | 1989 | https://conductscience.org/library/papers/2784973 | PubMed |
| 14 | 2574255 | Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. | Lancet | 1989 | https://conductscience.org/library/papers/2574255 | PubMed |
| 15 | 2392131 | Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. | N Engl J Med | 1990 | https://conductscience.org/library/papers/2392131 | PubMed |
| 16 | 1678095 | Adverse reactions to co-trimoxazole in HIV infection. | Lancet | 1991 | https://conductscience.org/library/papers/1678095 | PubMed |
| 17 | 1686233 | Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. | Drug Metab Dispos | 1991 | https://conductscience.org/library/papers/1686233 | PubMed |
| 18 | 1587066 | Sulfamethoxazole is metabolized to the hydroxylamine in humans. | Clin Pharmacol Ther | 1992 | https://conductscience.org/library/papers/1587066 | PubMed |
| 19 | 1617949 | MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. | Comput Biol Med | 1992 | https://conductscience.org/library/papers/1617949 | PubMed |
| 20 | 7981016 | Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7981016 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41344065 | N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation. | Drug Metab Dispos | 2025 | https://conductscience.org/library/papers/41344065 | PubMed |
| 30734913 | Fate of 14C-acetyl sulfamethoxazole during the activated sludge process. | Environ Sci Pollut Res Int | 2019 | https://conductscience.org/library/papers/30734913 | PubMed |
| 28603631 | Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk. | Pharmacol Res Perspect | 2017 | https://conductscience.org/library/papers/28603631 | PubMed |
| 16603214 | Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts. | Toxicol Appl Pharmacol | 2006 | https://conductscience.org/library/papers/16603214 | PubMed |
| 11600390 | Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11600390 | PubMed |
| 11350866 | Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11350866 | PubMed |
| 9010640 | Role of viral infections in the induction of adverse drug reactions. | Drug Saf | 1997 | https://conductscience.org/library/papers/9010640 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7654479
GET https://conductscience.org/api/papers/v1/7654479/references?page=2